Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Bitcoin price predictions include an initial $100,000 target after the Boxing Day options expiry completes, this worth a record $23.7 billion.
Crypto borrowing activity is undergoing a huge shift as decentralized finance (DeFi) contracts sharply during this latest current market correction while c...
Nike, UiPath gain in premarket; Intel falls
European bourses tracked moderately higher midday Wednesday as traders embraced mining and oil shar
Intel shares slide after report Nvidia halts testing of 18A process
BofA data shows largest equity outflows in nearly two months
US auto safety agency probes Tesla Model 3 emergency door release
Antitrust probe targets Meta's dominance over AI chatbot access via WhatsApp.
Driverless future gains momentum with global robotaxi deployments
KrakenâEUR(TM)s pending IPO and the wave of crypto companies seeking public listings may help the industry attract more TradFi capital.
Weight-loss pill approval set to accelerate food industry product overhauls